Displaying drugs 12176 - 12200 of 12282 in total
Lactobacillus coryniformis K8
Lactobacillus is a common bacteria found in the gut with Lactobacillus coryniformis K8 being originally isolated from artisan goat cheese.
Investigational
Matched Description: … Lactobacillus is a common bacteria found in the gut with Lactobacillus coryniformis K8 being originally …
XL228
XL228 is a novel anticancer compound designed to inhibit the insulin-like growth factor type-1 receptor (IGF1R), Src and Abl tyrosine kinases – targets that play crucial roles in cancer cell proliferation, survival and metastasis.
Investigational
Matched Description: … XL228 is a novel anticancer compound designed to inhibit the insulin-like growth factor type-1 receptor …
Onercept
Investigational
Lestaurtinib
Investigational
SNS-032
Investigational
Xaliproden
Investigational
Zenarestat
Experimental
Dociparstat sodium
Investigational
NPS-2143
Investigational
ENMD-1198
Investigational
RG-7795
Investigational
Plinabulin
Investigational
PRX-07034
Investigational
Canertinib
Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
Investigational
Matched Description: … Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Fradafiban
Investigational
Razuprotafib
Razuprotafib, also known as AKB-9778, is a small-molecule inhibitor restoring Tie2 activation by inhibiting VE-PTP.[L27171,L27176] In investigations against diabetes and COVID-19, razuprotafib is self-administered by patients through subcutaneous injection.
Investigational
Matched Description: … Razuprotafib, also known as AKB-9778, is a small-molecule inhibitor restoring Tie2 activation by inhibiting …
SGX-523
A MET receptor tyrosine kinase inhibitor.
Investigational
Matched Description: … A MET receptor tyrosine kinase inhibitor. …
Cariporide
Investigational
RAV12
RAV12 is investigated for use/treatment in solid tumors. RAV12 is a solid. RAV12 is a chimeric antibody that recognizes RAAG12, an N-linked carbohydrate antigen found on gastric, colon, pancreatic, prostate, ovarian, breast, and kidney cancer cells.
Investigational
Matched Description: … RAV12 is a solid. ... RAV12 is a chimeric antibody that recognizes RAAG12, an N-linked carbohydrate antigen found on gastric …
TBC-3711
TBC3711 is a next-generation endothelin antagonist that is being studied through oral and intravenous formulations by Encysive Pharmaceuticals.
Investigational
Matched Description: … TBC3711 is a next-generation endothelin antagonist that is being studied through oral and intravenous …
Matched Categories: … Endothelin A Receptor Antagonists …
Matched Categories: … Endothelin A Receptor Antagonists …
Latiglutenase
Investigational
Morphine glucuronide
Investigational
REV131
rEV131 is in development for allergic rhinitis, asthma and several inflammatory eye diseases. It is a topically delivered small protein that acts as an anti-inflammatory agent.
Investigational
Matched Description: … It is a topically delivered small protein that acts as an anti-inflammatory agent. …
Elvucitabine
Investigational
Vasomera
Investigational
Displaying drugs 12176 - 12200 of 12282 in total